GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » EBITDA Margin %

Novomics Co (XKRX:283100) EBITDA Margin % : -1,175.51% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Novomics Co's EBITDA for the six months ended in Dec. 2023 was ₩-2,234.7 Mil. Novomics Co's Revenue for the six months ended in Dec. 2023 was ₩190.1 Mil. Therefore, Novomics Co's EBITDA margin for the quarter that ended in Dec. 2023 was -1,175.51%.


Novomics Co EBITDA Margin % Historical Data

The historical data trend for Novomics Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co EBITDA Margin % Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -64,761.33 -44,147.50 -1,647.72 -2,202.11 -1,175.51

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin % Get a 7-Day Free Trial -64,761.33 -44,147.50 -1,647.72 -2,202.11 -1,175.51

Competitive Comparison of Novomics Co's EBITDA Margin %

For the Biotechnology subindustry, Novomics Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Novomics Co's EBITDA Margin % falls into.


;
;

Novomics Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Novomics Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-2234.672/190.103
=-1,175.51 %

Novomics Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-2234.672/190.103
=-1,175.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novomics Co  (XKRX:283100) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Novomics Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Novomics Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines